Why is Sanofi India falling/rising?

As of 26-Aug, Sanofi India Ltd's stock price is currently at 5,112.35, reflecting a decline of 107.65 points or 2.06%. The stock has been underperforming, having fallen for three consecutive days with a total decline of 3.11% during this period. It has also touched an intraday low of Rs 5,077, indicating significant selling pressure. Over the past week, the stock has decreased by 1.26%, and its performance over the last month shows a substantial drop of 12.46%. Despite high management efficiency and a favorable debt-to-equity ratio, the stock's negative trajectory is influenced by poor long-term growth metrics, including a 24.54% decline in returns over the past year and a 9.4% decrease in profits.
In the broader market context, Sanofi India's recent performance contrasts with the Sensex, which has only declined by 1.05% over the same week. The stock's liquidity is adequate for trading, but a significant drop in delivery volume suggests waning investor interest. The company's flat results in the most recent quarter, with net sales and profit before tax falling sharply compared to previous averages, further contribute to the negative sentiment surrounding the stock. Overall, the combination of underperformance in both short-term and long-term metrics, alongside declining investor participation, indicates a challenging environment for Sanofi India Ltd.